Overexpression of the PD-L1 protein (a kind of immune checkpoint) on the cancer cells is a major immune evasion mechanism, and antibodies to blockade the PD-1/PD-L1 interaction could normalize anti-tumor immunity. This evidence concerns the gene CD274 and neoplasm.